Holopack Verpackungstechnik GmbH (manufacturing of unpackaged product (solution preparation)/sterilizing filtration and filling, primary and secondary packaging, batch control (endotoxins and sterility))

The drug is intended for the treatment of chronic pulmonary infection caused by the bacterium Pseudomonas aeruginosa in patients with cystic fibrosis.

Dosage form: solution, for inhalation

ATC: J01GB01